Showing 1 - 4 results of 4 for search 'G.A.P. Nieuwenhuijzen', query time: 0.03s Refine Results
  1. 1
    Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study

    Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study by J. C. H. B. M. Luijten, P. A. J. Vissers, L. Brom, M. de Bièvre, J. Buijsen, T. Rozema, N. Haj Mohammad, P. van Duijvendijk, E. A. Kouwenhoven, W. J. Eshuis, C. Rosman, P. D. Siersema, H. W. M. van Laarhoven, R. H. A. Verhoeven, G. A. P. Nieuwenhuijzen, M. J. Westerman

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Team dynamics and clinician’s experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study

    Team dynamics and clinician’s experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study by J.C.H.B.M. Luijten, M.J. Westerman, G.A.P. Nieuwenhuijzen, J.E.W. Walraven, M.N. Sosef, L.V. Beerepoot, R. van Hillegersberg, K. Muller, R. Hoekstra, J.J.G.H.M. Bergman, P.D. Siersema, H.W.M. van Laarhoven, C. Rosman, L. Brom, P.A.J. Vissers, R.H.A. Verhoeven, R.H.A. Verhoeven

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial

    Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled... by A. van der Hout, C.F. van Uden-Kraan, K. Holtmaat, F. Jansen, B.I. Lissenberg-Witte, G.A.P. Nieuwenhuijzen, J.A. Hardillo, R.J. Baatenburg de Jong, N.L. Tiren-Verbeet, D.W. Sommeijer, K. de Heer, C.G. Schaar, R.J.E. Sedee, K. Bosscha, M.W.M. van den Brekel, J.F. Petersen, M. Westerman, J. Honings, R.P. Takes, I. Houtenbos, W.T. van den Broek, R. de Bree, P. Jansen, S.E.J. Eerenstein, C.R. Leemans, J.M. Zijlstra, P. Cuijpers, L.V. van de Poll-Franse, I.M. Verdonck-de Leeuw

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

    Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEN... by K. van den Berg, D. P. Schaap, E. L. K. Voogt, T. E. Buffart, H. M. W. Verheul, J. W. B. de Groot, C. Verhoef, J. Melenhorst, J. M. L. Roodhart, J. H. W. de Wilt, H. L. van Westreenen, A. G. J. Aalbers, M. van ‘t Veer, C. A. M. Marijnen, J. Vincent, L. H. J. Simkens, N. A. J. B. Peters, M. Berbée, I. M. Werter, P. Snaebjornsson, H. M. U. Peulen, I. G. van Lijnschoten, M. J. Roef, G. A. P. Nieuwenhuijzen, J. G. Bloemen, J. M. W. E. Willems, G. J. M. Creemers, J. Nederend, H. J. T. Rutten, J. W. A. Burger

    Published 2022-09-01
    Get full text
    Article

Search Tools: